企業プロフィール
Adverum Biotechnologies 株価・ニュース・カタリスト
- ティッカー:
- ADVM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for ADVM.
企業概要
事業概要
Adverum Biotechnologies is a gene-therapy company focused on ophthalmology and retinal disease. Its story centers on whether durable ocular gene therapy can create value in a difficult but high-unmet-need space.
所在地とセクター分類
Adverum is headquartered in the United States and listed on NASDAQ. It sits in gene therapy and ophthalmology biotechnology.
ビジネスモデルの特徴
The company depends on clinical and safety data, vector and manufacturing execution, and the ability to keep a narrow ocular pipeline funded. Investors watch readouts and strategic progress closely.
バイオ業界での位置付け
Adverum occupies a specialized ophthalmic gene-therapy niche within biotech. The stock is catalyst-sensitive because the platform still needs to prove a strong and durable safety-efficacy balance.
今後のカタリスト
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。